|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.3 TWD | 0.00% |
|
+1.26% | -4.52% |
| 05-03 | TCI GENE Inc. Approves the Cash Dividend for the Year Ended December 31, 2023 | CI |
| 03-15 | TCI GENE Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
TCI GENE Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 333.86 million compared to TWD 424.02 million a year ago. Net income was TWD 11.67 million compared to TWD 72.15 million a year ago.
Basic earnings per share from continuing operations was TWD 0.44 compared to TWD 2.95 a year ago. Diluted earnings per share from continuing operations was TWD 0.44 compared to TWD 2.93 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.52% | 65.22M | |
| -18.02% | 8.42B | |
| +72.32% | 4.35B | |
| +7.88% | 2.74B | |
| -56.54% | 1.78B | |
| -15.45% | 1.7B | |
| -16.52% | 1.47B | |
| +15.43% | 1.19B | |
| -49.10% | 1.03B | |
| -21.78% | 927M |
TCI GENE INC. 
